TX HB1788 | 2023-2024 | 88th Legislature

Status

Spectrum: Moderate Partisan Bill (Republican 8-1)
Status: Introduced on January 27 2023 - 25% progression, died in chamber
Action: 2023-05-01 - Laid on the table subject to call
Text: Latest bill text (Comm Sub) [HTML]

Summary

Relating to the labeling of analogue and cell-cultured products.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating to the labeling of analogue and cell-cultured products.

Sponsors


History

DateChamberAction
2023-05-01HouseLaid on the table subject to call
2023-05-01HouseCompanion considered in lieu of SB 664
2023-04-25HousePostponed 5/1/23 10:00 AM
2023-04-25HouseRead 2nd time
2023-04-25HousePlaced on General State Calendar
2023-04-20HouseConsidered in Calendars
2023-04-20HouseCommittee report sent to Calendars
2023-04-19HouseCommittee report distributed
2023-04-19HouseComte report filed with Committee Coordinator
2023-04-14HouseReported favorably as substituted
2023-04-14HouseCommittee substitute considered in committee
2023-04-14HouseConsidered in formal meeting
2023-04-03HouseLeft pending in committee
2023-04-03HouseTestimony taken/registration(s) recorded in committee
2023-04-03HouseConsidered in public hearing
2023-04-03HouseScheduled for public hearing on . . .
2023-03-07HouseReferred to Public Health
2023-03-07HouseRead first time
2023-01-27HouseFiled

Same As/Similar To

SB664 (Same As) 2023-05-15 - Effective on 9/1/23
SB664 (Same As) 2023-05-15 - Effective on 9/1/23

Subjects


Texas State Sources


Bill Comments

feedback